atezolizumab,oxaliplatin,5-fluorouracil,l-leucovorin,bevacizumab,irinotecan
roche
[' bev ', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezo', 'atezotribe']
 atezotribe trial- builds upon our understanding of immune checkpoint inhibition for pmmr mcrc. addition of atezolizumab to folfoxiri + bev improves pfs and os amongst patients with pmmr and tmb-high or high immunoscore. ph3 underway!
#asco23 
GI Radiation Oncologist | Associate PD @MayoRadOnc @MayoClinic | Passions for #PatientCare, #MedEd, QoL, #PublicHealth, and #ClinicalTrials | Views are my own